Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression

Avermectin induces P-glycoprotein expression in S2 cells via the calcium/calmodulin/NF-κB pathway

(2013) Liang Luo et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Cyclooxygenase-2 Regulated by the Nuclear Factor-κB Pathway Plays an Important Role in Endometrial Breakdown in a Female Mouse Menstrual-like Model

(2013) Xiangbo Xu et al.   ENDOCRINOLOGY

Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme

(2013) Ai-Yan Xing et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity

(2013) Youn-Hee Choi et al.   EXPERIMENTAL EYE RESEARCH

Regulation of the MDR1 promoter by E2F1 and EAPP

(2013) Peter Andorfer et al.   FEBS LETTERS

Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide

(2013) Dajun Liu et al.   Future Oncology

Dioscin Restores the Activity of the Anticancer Agent Adriamycin in Multidrug-Resistant Human Leukemia K562/Adriamycin Cells by Down-Regulating MDR1 via a Mechanism Involving NF-κB Signaling Inhibition

(2013) Lijuan Wang et al.   JOURNAL OF NATURAL PRODUCTS

NF-κB-dependent IL-8 induction by prostaglandin E2receptors EP1and EP4

(2012) F Neuschäfer-Rube et al.   BRITISH JOURNAL OF PHARMACOLOGY

Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells

(2012) Yi Hong et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-κB in R-HepG2 Cell Line

(2012) Jianguo Sun et al.   PLoS One

MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines

(2012) Radosław Januchowski et al.   Biomed Research International

Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo

(2010) Afraa Zrieki et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib

(2010) Chen Chen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line

(2009) Karnati R. Roy et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: Role of COX-2 and MDR-1

(2008) Kalle M. Arunasree et al.   LEUKEMIA RESEARCH